Publications

For more publications: click google scholar

1. Ha Young Jang, Boyoon Choi, In-Wha Kim, Hye Ryun Kang, Jung Mi Oh. Risk factors of Hypersensitivity Reactions to Carboplatin: A Systematic Review and Meta-analysis. JACI: In Practice. Articles in Press. December 24, 2024. DOI: 10.1016/j.jaip.2024.12.021  (2023 JCR 4/39, 9.0%)

2. Hee Yeon Kay#, Ha Young Jang#, In-Wha Kim, Jung Mi Oh. Fibrates and risk of congenital malformations: a nationwide cohort study in South Korea. Arch Gynecol Obstet. 2024 Oct;310(4):1967-1973; doi: 10.1007/s00404-023-07357-2. (#: Co-first)

3. Ha Young Jang, In-Wha Kim, and Jung Mi Oh. Comparative Safety Analysis of Empagliflozin in Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease versus Normal Kidney Function: A Nationwide Cohort Study in Korea. Pharmaceutics 2023, 15(10), 2394; https://doi.org/10.3390/pharmaceutics15102394

4. Ha Young Jang, Yon Su Kim, and Jung Mi Oh. Clinical Effectiveness of Renal Transplant Outpatient Pharmaceutical Care Services in Korea. Healthcare 2023, 11(18), 2597; https://doi.org/10.3390/healthcare11182597

5. Ha Young Jang, Hyun Kyung Lee, Chae Jeong Kim, Sung-Soo Yoon, In-Wha Kim, and Jung Mi Oh. Carfilzomib’s Real-World Safety Outcomes in Korea: Target Trial Emulation Study Using Electronic Health Records. International Journal of Environmental Research and Public Health 19, no. 20: 13560. https://doi.org/10.3390/ijerph192013560

6. Ha Young Jang, Jung Mi Oh and In-Wha Kim. Drug repurposing using meta-analysis of gene expression in Alzheimer’s disease. Frontiers in Neuroscience 16:989174. https://doi.org/10.3389/fnins.2022.989174

7. Ha Young Jang, In-Wha Kim and Jung Mi Oh. Using Real-World Data for Supporting Regulatory Decision Making: Comparison of Cardiovascular and Safety Outcomes of an Empagliflozin Randomized Clinical Trial Versus Real-World Data. Frontiers in Pharmacology 2022 August 13:928121. doi: 10.3389/fphar.2022.928121.

8. Ha Young Jang, Jihyeon Song, Jae Hyun Kim, Howard Lee, In-Wha Kim, Bongki Moon, and Jung Mi Oh. Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information. npj Digital Medicine 2022 June 11;5:88. doi: 10.1038/s41746-022-00639-0.  (2023 JCR 2/138, 0.01%)

9. Ha Young Jang, In-Wha Kim and Jung Mi Oh. Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study. Front. Oncol. 2022 April 07;12:858855. doi: 10.3389/fonc.2022.858855 

10. Ha Young Jang, Jae Hyun Kim , Yun-Kyoung Song , Ju-Young Shin , Hae-Young Lee , Yong Min Ahn , Jung Mi Oh* and In-Wha Kim. Antidepressant Use and the Risk of Major Adverse Cardiovascular Events in Patients Without Known Cardiovascular Disease: A Retrospective Cohort Study. Front. Pharmacol. 2020 Dec 10;11:594474. 

11. Ha Young Jang, Yun-Kyoung Song, Jae Hyun Kim, Myeong Gyu Kim, Nayoung Han, Hae-Young Lee, In-Wha Kim, Jung Mi Oh. Impact of depression on change in coronary heart disease risk status: the Korean Genome and Epidemiology Study (KoGES) Therapeutics and Clinical Risk Management 2018:14 1–8.